Literature DB >> 12669350

Activation of the cellular mitogen-activated protein kinase pathways ERK, P38 and JNK during Toxoplasma gondii invasion.

A Valère1, R Garnotel, I Villena, M Guenounou, J M Pinon, D Aubert.   

Abstract

Host cell invasion is essential for the pathogenicity of the obligate intracellular protozoan parasite Toxoplasma gondii. In the present study, we evaluated the ability of T. gondii tachyzoites to trigger phosphorylation of the different mitogen-activated protein kinases (MAPK) in human monocytic cells THP1. Kinetic experiments show that the peak of extracellular-signal-regulated kinase (ERK1/2), P38 and cjun-NH2 terminal kinase (JNKs) phosphorylation occurs between 10 and 60 min. The use of specific inhibitors of ERK1/2, P38 and JNK1/2 phosphorylation indicates the specificity of MAPKs phosphorylation during invasion. Signaling through cellular and parasite mitogen-activated protein (MAP) kinase pathways appears to be critical for T. gondii invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669350     DOI: 10.1051/parasite/2003101p59

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  22 in total

1.  TRAF6-dependent mitogen-activated protein kinase activation differentially regulates the production of interleukin-12 by macrophages in response to Toxoplasma gondii.

Authors:  Nicola J Mason; Jim Fiore; Takashi Kobayashi; Katherine S Masek; Yongwon Choi; Christopher A Hunter
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.

Authors:  Zhaoshou Yang; Yongheng Hou; Taofang Hao; Hee-Sool Rho; Jun Wan; Yizhao Luan; Xin Gao; Jianping Yao; Aihua Pan; Zhi Xie; Jiang Qian; Wanqin Liao; Heng Zhu; Xingwang Zhou
Journal:  Mol Cell Proteomics       Date:  2017-01-13       Impact factor: 5.911

3.  Cell surface heparan sulfate promotes replication of Toxoplasma gondii.

Authors:  Joseph R Bishop; Brett E Crawford; Jeffrey D Esko
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Involvement of MAPK activation in chemokine or COX-2 productions by Toxoplasma gondii.

Authors:  Ji-Young Kim; Myoung-Hee Ahn; Hyun-Ouk Song; Jong-Hak Choi; Jae-Sook Ryu; Duk-Young Min; Myung-Hwan Cho
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

5.  Recurrent headaches may be caused by cerebral toxoplasmosis.

Authors:  Joseph Prandota; Anna Gryglas; Aleksander Fuglewicz; Agata Zesławska-Faleńczyk; Barbara Ujma-Czapska; Leszek Szenborn; Janusz Mierzwa
Journal:  World J Clin Pediatr       Date:  2014-08-08

6.  TgERK7 is involved in the intracellular proliferation of Toxoplasma gondii.

Authors:  Zhong-Yuan Li; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu; Quan Liu
Journal:  Parasitol Res       Date:  2016-05-06       Impact factor: 2.289

7.  Diminazene aceturate (Berenil) downregulates Trypanosoma congolense-induced proinflammatory cytokine production by altering phosphorylation of MAPK and STAT proteins.

Authors:  Shiby M Kuriakose; Chukwunonso Onyilagha; Rani Singh; Ping Jia; Jude E Uzonna
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

8.  Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction.

Authors:  Pedro Morgado; Yi-Ching Ong; John C Boothroyd; Melissa B Lodoen
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

9.  Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Authors:  Shankar Mukherjee; Huan Huang; Stefka B Petkova; Chris Albanese; Richard G Pestell; Vicki L Braunstein; George J Christ; Murray Wittner; Michael P Lisanti; Joan W Berman; Louis M Weiss; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 10.  Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.

Authors:  J Leng; B A Butcher; E Y Denkers
Journal:  Parasite Immunol       Date:  2009-12       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.